Blue Gold Finalizes Highly Dilutive Financing Terms with $3.00 Convertible Notes and $0.01 Warrants

summarizeSummary

This 424B3 prospectus supplement provides critical details regarding the omnibus amendment to convertible notes and warrants with 3i, LP, which was previously disclosed in a 6-K filing on January 26, 2026. The finalized terms are highly unfavorable for existing shareholders, featuring a fixed conversion price of $3.00 for senior convertible notes (a significant discount to the current stock price of $3.77) and an extremely low $0.01 exercise price for warrants. These terms, combined with a secondary offering of over 1.2 million shares by the selling shareholder (from which the company receives no proceeds), indicate substantial potential dilution. While the agreement includes daily selling restrictions for 3i, the overall structure suggests the company is securing capital under distressed conditions, significantly impacting the investment thesis.

check_boxKey Events

• Finalized Highly Dilutive Financing Terms

  Details of the omnibus amendment to existing convertible notes and warrants with 3i, LP are finalized, setting a fixed conversion price of $3.00 for notes and a $0.01 exercise price for warrants. This represents a significant discount to the current stock price.

• New Convertible Note and Warrants Issued

  The company issued a new $1.63 million senior convertible note and 64,590 warrants to 3i, LP, with similar highly dilutive terms, further increasing potential dilution.

• Secondary Offering by Selling Shareholder

  A secondary offering of up to 1,215,299 ordinary shares by 3i, LP is registered. The company will not receive any proceeds from these sales, creating an overhang on the stock.

• Selling Restrictions Imposed

  The selling shareholder, 3i, LP, has agreed to daily selling limits on their shares, providing some mitigation against immediate market pressure, but still indicating intent to sell.

auto_awesomeAnalysis

This 424B3 prospectus supplement provides critical details regarding the omnibus amendment to convertible notes and warrants with 3i, LP, which was previously disclosed in a 6-K filing on January 26, 2026. The finalized terms are highly unfavorable for existing shareholders, featuring a fixed conversion price of $3.00 for senior convertible notes (a significant discount to the current stock price of $3.77) and an extremely low $0.01 exercise price for warrants. These terms, combined with a secondary offering of over 1.2 million shares by the selling shareholder (from which the company receives no proceeds), indicate substantial potential dilution. While the agreement includes daily selling restrictions for 3i, the overall structure suggests the company is securing capital under distressed conditions, significantly impacting the investment thesis.